We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Short Sleepers Risk Type 2 Diabetes and Heart Disease

By HospiMedica International staff writers
Posted on 21 Sep 2010
A new study has found that people who sleep less than six hours a night may be three times more likely to develop incident-impaired fasting glycemia (IFG), a condition that leads to diabetes and heart disease. More...


Researchers at the University of Warwick (United Kingdom) and the State University of New York (Buffalo, USA) conducted a nested case-control study involving 1,455 participants who were free of type 2 diabetes and known cardiovascular disease at baseline (1996-2001), and who were re-examined during 2003-2004. All participants were aged between 35 and 79 years old, and all completed a clinical examination that included measures of resting blood pressure, height, and weight. They also completed questionnaires about their general health, wellbeing, and sleeping patterns. Average sleep duration was categorized as short (less than 6 hours), mid-range (6 to 8 hours), and long (over 8 hours).

The results, after adjustment for several diabetes risk factors, showed that the odds ratio (OR) of IFG among short sleepers was 3.0, compared to mid-range sleepers. No association was identified between long sleep and IFG. Adjustment for insulin resistance attenuated the association, but only among short sleepers. The study was published in the September 2010 issue of the Annals of Epidemiology.

"Previous studies have shown that short sleep duration results in a 28% increase in mean levels of the appetite stimulating hormone ghrelin so it can affect feeding behaviors,” said study coauthor Saverio Stranges, M.D., of the health sciences research institute at the University of Warwick. "Other studies have also shown that a lack of sleep can decrease glucose tolerance and increases the production of cortisol, a hormone produced in response to stress.”

The longer-term effects of sleep deprivation have been linked to weight gain, diabetes, high blood pressure, heart problems, depression, and substance abuse. There is a decrease in the amount of leptin, an appetite-suppressing hormone, as well as the rise in ghrelin. Too little sleep also interferes with the body's ability to regulate glucose and can cause inflammation leading to heart problems and a rise in blood pressure.

Related Links:

University of Warwick
State University of New York




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.